Form 4: Adam Portnoy Reports Acquisition of Diversified Healthcare Trust Shares
SEC Form 4 Filing
Adam Portnoy, a Director of Diversified Healthcare Trust, reports acquiring 74,626 common shares through an equity compensation plan.
Summary
- On September 11, 2024, Adam D. Portnoy, a Director of Diversified Healthcare Trust (DHC), acquired 74,626 common shares of beneficial interest.
- The acquisition was part of the Issuer's equity compensation plan.
- Following the transaction, Mr. Portnoy directly owns 326,036.55 common shares.
- Mr. Portnoy may also be deemed a beneficial owner of 23,250,019 shares held by ABP Trust, where he serves as the sole trustee, officer, and controlling shareholder, although he disclaims beneficial ownership except to the extent of his pecuniary interest.
- The form was signed on September 13, 2024.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.
Positives
- The acquisition of shares through an equity compensation plan aligns Mr. Portnoy's interests with those of the shareholders.
Industry Context
This filing is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency regarding the holdings of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder confidence as it shows the director's investment in the company.
Key Dates
| Date | Description |
|---|---|
| 09/11/2024 | Date of transaction: Adam Portnoy acquired 74,626 common shares. |
| 09/13/2024 | Date of signature: Form 4 signed by Adam D. Portnoy. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.